Fornasari, Diego Maria Michele https://orcid.org/0000-0002-9668-3103
Funding for this research was provided by:
Alfasigma S.p.A.
Article History
Received: 18 December 2025
Accepted: 13 February 2026
First Online: 13 March 2026
Declarations
:
: Diego Maria Michele Fornasari received fees as congress speaker or consultant from the following pharmaceutical companies: Angelini, Abiogen, Alfasigma (the manufacturer of acetyl- l -carnitine), Chiesi, Istituto Gentili, Grunentahl, Molteni, Sandoz, SPA, Viatris, Zambon.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by the author.